What is Vidoflumimus used for?

Vidoflumimus is being studied for several conditions, including multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease.

Is Vidoflumimus approved for treating COVID-19?

Vidoflumimus is being researched for COVID-19, but it is currently in the clinical trial phase and is not an approved treatment.

How does Vidoflumimus work in the body?

It works as a dihydroorotate dehydrogenase inhibitor, which means it targets a specific enzyme to affect immune activity.

What stage of testing is Vidoflumimus in?

Vidoflumimus is currently in Phase 3 clinical trials for some of its intended uses.

Can Vidoflumimus treat rheumatoid arthritis?

Research is ongoing to see if Vidoflumimus can help with rheumatoid arthritis, but it is still in the testing phase.

Is Vidoflumimus a small molecule drug?

Yes, Vidoflumimus is classified as a small molecule drug.

vidofludimus | CAS 717824-30-1 | XPRDUGXOWVXZLL

Loading compound...

Dihydroorotate dehydrogenase inhibitor

Vidoflumimus (also known as 4SC-101) is a small molecule drug currently being studied in clinical trials. It works by inhibiting an enzyme called dihydroorotate dehydrogenase. Researchers are investigating its potential use for various inflammatory and autoimmune conditions, including multiple sclerosis and rheumatoid arthritis.

How it worksVidoflumimus works by blocking an enzyme called dihydroorotate dehydrogenase, which helps regulate certain immune responses.

Used for

Relapsing-remitting multiple sclerosisMultiple sclerosisUlcerative colitisRheumatoid arthritisInflammatory bowel diseaseSclerosing cholangitisCOVID-19

Conditions

Relapsing-remitting multiple sclerosisMultiple sclerosisUlcerative colitisRheumatoid arthritisInflammatory bowel diseaseSclerosing cholangitisCOVID-19

Class

Dihydroorotate dehydrogenase inhibitorImmune System

How to take

Vidoflumimus is currently in clinical development (Phase 3) and is not yet an FDA-approved medication for any condition listed above.

Talk to your doctor

Questions to ask

·Is Vidoflumimus a candidate for my condition?
·What are the current clinical trial stages for Vidoflumimus?
·How does a dihydroorotate dehydrogenase inhibitor work?

Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.

How to take

Talk to your doctor

Frequently asked questions (6)